Expert Medical Council

CLL Society has established an Expert Medical Council which is comprised of a diverse group of world-renowned CLL experts. These trusted individuals work with our medical writers, scientific contributors, and staff to verify that all content is medically accurate, reflects best practices, and conveys the latest evidence-based information.

Syed Ali Abutalib, MD

Co-Director, Hematology and Cellular Therapy Programs
Director, Clinical NMDP and CTCA Apheresis Programs
Cancer Treatment Centers of America, Affiliate of City of Hope
Zion, Illinois

Farrukh T. Awan, MD

Associate Professor of Internal Medicine
Director of Lymphoid Malignancies Program
Harold C. Simmons Comprehensive Cancer Center
University of Texas Southwestern Medical Center
Dallas, Texas

Jacqueline C. Barrientos, MD, MS

Chief of Hematologic Malignancies
Director of Oncological Research
Adjunct Professor of Medicine, Zucker School of Medicine at Hofstra/Northwell
Adjunct Associate Professor, Feinstein Institutes for Medical Research
Mount Sinai Medical Center Comprehensive Cancer Center
Miami Beach, Florida

Danielle M. Brander, MD

Division of Hematologic Malignancies & Cellular Therapy
Duke Cancer Institute
Durham, North Carolina

Jennifer R. Brown, MD, PhD

Worthington and Margaret Collette Professor of Medicine in the Field of Hematologic Oncology, Harvard Medical School
Director, CLL Center
Dana-Farber Cancer Institute
Boston, Massachusetts

John M. Burke, MD

Associate Chair, US Oncology Hematology Research Program
Rocky Mountain Cancer Centers
Aurora, Colorado

John C. Byrd, MD

The Gordon and Helen Hughes Taylor Professor and Chair
Department of Internal Medicine
University of Cincinnati College of Medicine
Cincinnati, Ohio

Bruce D. Cheson, MD, FACP, FAAAS, FASCO

The Center for Cancer and Blood Disorders
Bethesda, Maryland

Catherine C. Coombs, MD

Associate Clinical Professor of Medicine
Chao Family Comprehensive Cancer Center
University of California, Irvine
Irvine, California

Wei Ding, MD, PhD

Associate Professor of Medicine, Consultant, Hematology
Mayo Clinic
Rochester, Minnesota

Ian Flinn, MD, PhD

Director, Lymphoma Research
Sarah Cannon Center for Blood Cancer
Nashville, Tennessee

Richard R. Furman, MD

Director of the CLL Research Center
Division of Hematology/Oncology
Weill Cornell Medical College
New York, New York

Carmen N. Janes, PharmD, BCOP

Clinical Pharmacy Specialist, Ambulatory Hematologic Malignancies
Department of Pharmacy
The Johns Hopkins Hospital
Baltimore, Maryland

Neil Kay, MD

Consultant, Division of Hematology
Mayo Clinic
Rochester, Minnesota

Thomas Kipps, MD, PhD

Professor of Medicine
Division of Hematology-Oncology
Deputy Director of Research
University of California, San Diego Moores Cancer Center
La Jolla, California

Adam Kittai, MD

Assistant Professor
Division of Hematology
The Ohio State University
Columbus, Ohio

Amber Koehler, PA-C

Assistant Professor of Medicine
Mayo Clinic Enterprise Lead CLL APP
Mayo Clinic Comprehensive Cancer Center
Rochester, MN

Jean Louise Koff, MD, MSc

Assistant Professor, Department of Hematology and Medical Oncology
Winship Cancer Institute of Emory University
Atlanta, Georgia

Lori Leslie, MD

Director, Indolent Lymphoma and Chronic Lymphocytic Leukemia Programs
Assistant Professor of Medicine, Hackensack Meridian School of Medicine
John Theurer Cancer Center
Hackensack, New Jersey

S. Shahzad Mustafa, MD

Lead Physician – Allergy, Immunology, & Rheumatology
Rochester Regional Health
Clinical Associate Professor of Medicine
University of Rochester School of Medicine and Dentistry
Rochester, New York

Chadi Nabhan, MD, MBA, FACP

Chairman – Precision Oncology Alliance
Caris Life Sciences
Chicago, Illinois

Krish Patel, MD

Director, Lymphoma Program
Interim Chief of Hematologic Malignancies and Cellular Therapies, Swedish Cancer Institute
Seattle, Washington

Tycel J. Phillips, MD

Associate Clinical Professor of Medicine
Department of Hematology & Hematopoietic Cell Transplantation
City of Hope Comprehensive Cancer Center
Duarte, California

Lindsey Roeker, MD

Medical Oncology/Hematology Fellow
Memorial Sloan Kettering Cancer Center
New York, New York

Steven T. Rosen, MD, FACP

Provost and Chief Scientific Officer
Director, Comprehensive Cancer Center and Beckman Research Institute
City of Hope Comprehensive Cancer Center
Duarte, California

Christina M. Russomanno, MS, RN, ANP-C, AOCN

Nurse Practitioner, Leukemia Service
Herbert Irving Comprehensive Cancer Center
Columbia University Irving Medical Center
New York City, New York

Mazyar Shadman, MD, MPH

Associate Professor, Division of Medical Oncology
University of Washington School of Medical Oncology
Associate Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center
Seattle, Washington

Sanjay Sharma, MD

St. Jude Medical Center
Fullerton, California

Tanya Siddiqi, MD

Director, Chronic Lymphocytic Leukemia Program, Toni Stephenson Lymphoma Center
Associate Clinical Professor, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center
Duarte, California

William G. Wierda, MD, PhD

Clinical Medical Director-Department of Leukemia, Division of Cancer Medicine
Professor, Department of Leukemia, Division of Cancer Medicine
Executive Medical Director, Inpatient Medical Services
The University of Texas MD Anderson Cancer Center
Houston, Texas

Adrian Wiestner, MD, PhD

Senior Investigator
Laboratory of Lymphoid Malignancies
National Heart, Lung, and Blood Institute (NHLBI)
National Institutes of Health (NIH)
Bethesda, Maryland

Heather Wolfe, MD

Assistant Professor of Medicine
Director of CLL Survivorship Program
Harold C. Simmons Comprehensive Cancer Center
University of Texas Southwestern Medical Center
Dallas, Texas

Jennifer Woyach, MD

D Warren Brown Professor of Leukemia Research
Section Head, CLL and Hairy Cell Leukemia
Associate Division Director for Clinical Research
Division of Hematology
Co-Director, Leukemia Research Program
Ohio State University Comprehensive Cancer Center
Columbus, Ohio